Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications--including single-cell 'omics technologies, flow cytometry, immunotherapy, and cell and gene therapy--deserve a next-generation approach to preparing samples for analysis. That’s why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization.
Location: South Korea, Geumcheon-gu
Employees: 51-200
Total raised: $30M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Muirwoods ... | muirwoodsv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.03.2022 | Series C | $15M | - |
| 16.10.2019 | Series B | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 16.03.2022 | Curiox Biosystems Closes $15M Series C Funding Round | Curiox Biosystems, Inc., a Woburn, Mass.-based leader in biological sample preparation automation, closed a $15m Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., Ltd and Quad ... |
| 18.10.2019 | Daily funding roundup - October 17th, 2019 | Rentgrata has raised $1M; Evervault has raised $3.2M; Versameb has raised $6.5M Rentgrata: Rentgrata sells renter data to landlords. Rentgrata has raised $1 million in funding from M25, Syndicate Fund, Right Side Capital Management and Neln... |
| 18.10.2019 | Singapore: Zig Ventures-backed Curiox raises $15m, eyes Korea IPO | Premium Curiox Biosystems, a bio-instrumentation company backed by Singapore-based venture investment firm Zig Ventures, has raised $15 million in its Series B funding round that it will use for global commercialisation activities. Continue... |
| 16.10.2019 | Curiox Biosystems Secures US$15M in Series B Funding | Curiox Biosystems, a Singapore-based developer of bioinstrumentation solutions used in cell analysis and therapy for the pharmaceutical and biotech industries, secured a Series B funding of US$15M. Backers included KB Investment, IMM Invest... |